Expression and immunoreactivity of an epitope of HCV in a foreign epitope presenting system

World Journal of Gastroenterology

Volumn 11, Issue 22, 2005, Pages 3363-3367

  Peng, Mei ^a   Dai, Chang Bai ^a   Chen, Yuan Ding ^a  

^a INSTITUTE OF MEDICAL BIOLOGY   (China)

Author keywords

Epitope; Epitope presenting system; HCV; Immunoreactivity

Indexed keywords

CAPSID PROTEIN; EPITOPE; VIRUS CAPSID ANTIGEN;

AMINO ACID SEQUENCE; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE SEQUENCE; GENETIC CODE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOREACTIVITY; NONHUMAN; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING;

EID: 21044434502     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i22.3363     Document Type: Article

References (24)

1. Itoh K, Suzuki K, Ishiwata S, Tezuka T, Mizugaki M, Suzuki T. Application of a recombinant Fab fragment from a phage display library for sensitive detection of a target antigen by an inhibition ELISA system. J Immunol Methods 1999; 223: 107-114
2. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-362
3. Choo QL, Weiner AJ, Overby LR, Kuo G, Houghton M, Bradley DW. Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis. Br Med Bull 1990; 46: 423-441
4. Ramsay ME, Balogun MA, Teo CG, Mortimer PP. Accuracy of perceptions of hepatitis B and C status. Injecting drug users need vaccination against hepatitis. B BMJ 2000; 320: 512-513
5. Lopez-Labrador FX, Ampurdanes S, Gimenez-Barcons M, Guilera M, Costa J, Jimenez de Anta MT, Sanchez-Tapias JM, Rodes J, Saiz JC. Relationship of the genomic complexity of hepatitis C virus with liver disease severity and response to interferon in patients with chronic HCV genotype 1b infection [correction of interferon]. Hepatology 1999; 29: 897-903
6. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362-364
7. Miyamura T, Saito I, Katayama T, Kikuchi S, Tateda A, Houghton M, Choo QL, Kuo G. Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: application to diagnosis and blood screening for posttransfusion hepatitis. Proc Natl Acad Sci USA 1990; 87: 983-987
8. Saito M, Hasegawa A, Kashiwakuma T, Kohara M, Sugi M, Miki K, Yamamoto T, Mori H, Ohta Y, Tanaka E. Performance of an enzyme-linked immunosorbent assay system for antibodies to hepatitis C virus with two new antigens (c11/c7). Clin Chem 1992; 38: 2434-2439
9. Wang YF, Brotman B, Andrus L, Prince AM. Immune response to epitopes of hepatitis C virus (HCV) structural proteins in HCV-infected humans and chimpanzees. J Infect Dis 1996; 173: 808-821
10. Ishida C, Matsumoto K, Fukada K, Matsushita K, Shiraki H, Maeda Y. Detection of antibodies to hepatitis C virus (HCV) structural proteins in anti-HCV-positive sera by an enzyme-linked immunosorbent assay using synthetic peptides as antigens. J Clin Microbiol 1993; 31: 936-940
11. Ray R, Khanna A, Lagging LM, Meyer K, Choo QL, Ralston R, Houghton M, Becherer PR. Peptide immunogen mimicry of putative E1 glycoprotein-specific epitopes in hepatitis C virus. J Virol 1994; 68: 4420-4426
12. Okamoto H, Kurai K, Okada S, Yamamoto K, Lizuka H, Tanaka T, Fukuda S, Tsuda F, Mishiro S. Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes. Virology 1992; 188: 331-341
13. Ching WM, Wychowski C, Beach MJ, Wang H, Davies CL, Carl M, Bradley DW, Alter HJ, Feinstone SM, Shih JW. Interaction of immune sera with synthetic peptides corresponding to the structural protein region of hepatitis C virus. Proc Natl Acad Sci USA 1992; 89: 3190-3194
14. Ferroni P, Mascolo G, Zaninetti M, Colzani D, Pregliasco F, Pirisi M, Barbone F, Gasparini V. Identification of four epitopes in hepatitis C virus core protein. J Clin Microbiol 1993; 31: 1586-1591
15. Moore JP, Cao Y, Conley AJ, Wyatt R, Robinson J, Gorny MK, Zolla-Pazner S, Ho DD, Koup RA. Studies with monoclonal antibodies to the V3 region of HIV-1 gp120 reveal limitations to the utility of solid-phase peptide binding assays. J Acquir Immune Defic Syndr 1994; 7: 332-339
16. Schutten M, Langedijk JP, Andeweg AC, Huisman RC, Meloen RH, Osterhaus AD. Characterization of a V3 domain-specific neutralizing human monoclonal antibody that preferentially recognizes non-syncytium-inducing human immunodeficiency virus type 1 strains. J Gen Virol 1995; 76(Pt 7): 1665-1673
17. Scodeller EA, Tisminetzky SG, Porro F, Schiappacassi M, De Rossi A, Chiecco-Bianchi L, Baralle FE. A new epitope presenting system displays a HIV-1 V3 loop sequence and induces neutralizing antibodies. Vaccine 1995; 13: 1233-1239
18. Clarke BE, Newton SE, Carroll AR, Francis MJ, Appleyard G, Syred AD, Highfield PE, Rowlands DJ, Brown F. Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein. Nature 1987; 330: 381-384
19. Burke KL, Dunn G, Ferguson M, Minor PD, Almond JW. Antigen chimaeras of poliovirus as potential new vaccines. Nature 1988; 332: 81-82
20. Brown AL, Francis MJ, Hastings GZ, Parry NR, Barnett PV, Rowlands DJ, Clarke BE. Foreign epitopes in immunodominant regions of hepatitis B core particles are highly immunogenic and conformationally restricted. Vaccine 1991; 9: 595-601
21. Krajden M. Molecular detection of hepatitis C virus: impact of detection methodology on clinical and laboratory correlations. Crit Rev Clin Lab Sci 1995; 32: 41-66
22. Roggendorf M, Lu M, Meisel H, Riffelmann M, Schreier E, Viazov S. Rational use of diagnostic tools in hepatitis C. J Hepatol 1996; 24(2 Suppl): 26-34
23. Chien DY, Choo QL, Tabrizi A, Kuo C, McFarland J, Berger K, Lee C, Shuster JR, Nguyen T, Moyer DL. Diagnosis of hepatitis C virus (HCV) infection using an immunodominant chimeric polyprotein to capture circulating antibodies: re-evaluation of the role of HCV in liver disease. Proc Natl Acad Sci USA 1992; 89: 10011-10015
24. Moore JP. The reactivities of HIV-1+ human sera with solid-phase V3 loop peptides can be poor predictors of their reactivities with V3 loops on native gp120 molecules. AIDS Res Hum Retroviruses 1993; 9: 209-219